APPLICATION
ANDA076403
TYPE
ANDA
ORIGINAL APPROVAL
2012-05-01
LATEST ACTION
2017-06-08
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
GABAPENTINPrescription
GABAPENTIN 250MG/5ML · SOLUTION · ORAL
Approval history
2017-06-08Labeling · Supplement 2 · standardAP
2012-05-01OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.